Grace Therapeutics, Inc.

Phase 3 AI-extracted

GTx-104

aSAH

Date

TBD

Phase 3 readout · Date TBD estimated

What's at stake Phase 3 trial results for GTx-104 in aSAH are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 8-K verified 15h ago

“Phase 3 STRIVE-ON trial results were presented at multiple major medical conferences over the last twelve months:”